SNAI1, a zinc finger transcription factor, not only acts as the master regulator of epithelial-mesenchymal transition (EMT) but also functions as a driver of cancer progression, including cell invasion, survival, immune regulation, stem cell properties, and metabolic regulation. The regulation of SNAI1 occurs at the transcriptional, translational, and predominant post-translational levels including phosphorylation, acetylation, and ubiquitination. Here, we discuss the regulation and role of SNAI1 in cancer metastasis, with a particular emphasis on epigenetic regulation and post-translational modifications. Understanding how signaling networks integrate with SNAI1 in cancer progression will shed new light on the mechanism of tumor metastasis and help develop novel therapeutic strategies against cancer metastasis.
|Journal||International Journal of Molecular Sciences|
|State||Published - Oct 1 2021|
Bibliographical noteFunding Information:
Author Contributions: All authors contributed to the manuscript content and editing for this review. B.D. wrote the manuscript. Y.W. wrote the manuscript, provided supervision and financial support. All authors have read and agreed to the published version of the manuscript.
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
- Post-translational modifications
ASJC Scopus subject areas
- Molecular Biology
- Computer Science Applications
- Physical and Theoretical Chemistry
- Organic Chemistry
- Inorganic Chemistry